← FDA Drug Approvals (Drugs@FDA)

VORICONAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2022-10-11

Drug application

FDA Application #

ANDA210849

Application type

Abbreviated New Drug Application (Generic)

Brand name

VORICONAZOLE

Generic name

Voriconazole

Active ingredients

VORICONAZOLE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

PHARMOBEDIENT

First approval

2022-10-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown